COMT Val108/158Met genotype modulates human sensory gating.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 21184832)

Published in Neuroimage on December 22, 2010

Authors

Tomislav Majic1, Johannes Rentzsch, Yehonala Gudlowski, Stefan Ehrlich, Georg Juckel, Thomas Sander, Undine E Lang, Georg Winterer, Jürgen Gallinat

Author Affiliations

1: Clinic for Psychiatry and Psychotherapy, Charité University Medicine, Campus Mitte, Berlin, Germany. tomislav.majic@charite.de

Articles by these authors

15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21

Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88

Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage (2007) 2.73

Retracted Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet (2003) 2.70

Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet (2006) 2.50

Take home maintenance medication in opiate dependence. Dtsch Arztebl Int (2013) 2.46

Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension (2004) 2.32

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) (2006) 2.23

Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet (2009) 2.12

Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov (2008) 2.05

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord (2004) 2.04

Automated probabilistic reconstruction of white-matter pathways in health and disease using an atlas of the underlying anatomy. Front Neuroinform (2011) 2.03

Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage (2004) 1.84

A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus (2008) 1.81

Disturbed structural connectivity is related to inattention and impulsivity in adult attention deficit hyperactivity disorder. Eur J Neurosci (2010) 1.79

Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci (2008) 1.78

A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol (2002) 1.77

Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77

Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing. Clin Neurophysiol (2004) 1.76

Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage (2007) 1.71

Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70

Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage (2004) 1.68

Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response. Eur J Neurosci (2011) 1.62

The attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.61

Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case-control trial. Am J Geriatr Psychiatry (2013) 1.60

Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull (2007) 1.59

The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl) (2007) 1.49

Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry (2009) 1.48

Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48

Valproate and GABAergic system effects. Neuropsychopharmacology (2003) 1.46

Effectiveness and cost of atypical versus typical antipsychotic treatment in a nationwide cohort of patients with schizophrenia in Germany. J Clin Psychopharmacol (2012) 1.46

BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology (2004) 1.44

Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology (2005) 1.44

Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol (2003) 1.43

Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res (2008) 1.42

Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci (2008) 1.41

Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J Neuroimmunol (2003) 1.39

An African patient with ziprasidone intolerance. J Clin Psychiatry (2005) 1.39

Predictive value of isolated epileptiform discharges for a favorable therapeutic response to antiepileptic drugs in nonepileptic psychiatric patients. J Clin Neurophysiol (2014) 1.39

Serum neurotrophins--a study on the time course and influencing factors in a large old age sample. Neurobiol Aging (2006) 1.38

Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med (2013) 1.36

Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev (2011) 1.33

Significance of SGK1 in the regulation of neuronal function. J Physiol (2010) 1.32

TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis. Lancet (2003) 1.30

Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci (2004) 1.28

CLCN2 variants in idiopathic generalized epilepsy. Nat Genet (2009) 1.26

Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophr Bull (2011) 1.26

Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25

Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol (2008) 1.21

Reduced thickness of medial orbitofrontal cortex in smokers. Biol Psychiatry (2010) 1.21

DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol (2014) 1.21

Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage (2005) 1.16

Multifaceted genomic risk for brain function in schizophrenia. Neuroimage (2012) 1.16

Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res (2009) 1.15

The neural correlates of subjective pleasantness. Neuroimage (2012) 1.15

Heritability of multivariate gray matter measures in schizophrenia. Twin Res Hum Genet (2012) 1.14

The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics (2013) 1.14

Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis. Biol Psychiatry (2012) 1.14

Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage (2008) 1.12

ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology (2008) 1.11

Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol (2007) 1.11

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.11

Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy. Ann Neurol (2014) 1.11

Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T. J Clin Psychopharmacol (2007) 1.11

Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI. Neuroimage (2005) 1.11

Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci (2008) 1.10

Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia. Schizophr Bull (2010) 1.10

Disability in people clinically at high risk of psychosis. Br J Psychiatry (2010) 1.10

Increased pain sensitivity in alcohol withdrawal syndrome. Eur J Pain (2009) 1.09

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J Immunol (2002) 1.09

Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09

Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res (2004) 1.08

An fMRI study of theory of mind in schizophrenic patients with "passivity" symptoms. Neuropsychologia (2008) 1.08

Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry (2005) 1.08

Comparison of ligand- and structure-based virtual screening on the DUD data set. J Chem Inf Model (2009) 1.08

Exploration of the genetic architecture of idiopathic generalized epilepsies. Epilepsia (2006) 1.07

A new role for nortriptyline in depression associated with vascular disease? Am J Psychiatry (2015) 1.07

Cognitive Reserve and the Risk of Postoperative Cognitive Dysfunction. Dtsch Arztebl Int (2017) 1.07

Different aspects of theory of mind in paranoid schizophrenia: evidence from a video-based assessment. Psychiatry Res (2010) 1.07

Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. Epilepsia (2013) 1.07

An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol (2010) 1.07

Allelic association of a truncation mutation of the KCNMB3 gene with idiopathic generalized epilepsy. Am J Med Genet B Neuropsychiatr Genet (2007) 1.06

Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology (2007) 1.06

Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia. PLoS One (2012) 1.06

Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice. Am J Hum Genet (2007) 1.06

RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release. Proc Natl Acad Sci U S A (2012) 1.06

Brains online: structural and functional correlates of habitual Internet use. Addict Biol (2014) 1.05